This report aims to provide detailed insights into the global medical
aesthetics market. It provides valuable information on the
type, procedure, application, and region in the market. Furthermore, the
information for these segments, by region, is also presented in this report.
Leading players in the market are profiled to study their product offerings and
understand the strategies undertaken by them to be competitive in this market.
Expected Revenue Growth Analysis:
The global Medical Aesthetics Market is projected to reach USD 15.9 billion by
2025 from USD 9.4 billion in
2020, at a CAGR of 10.9%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=885
Key Factors Driving Market Growth:
The
growth in medical aesthetics market is mainly driven by the growing adoption of
minimally invasive and noninvasive aesthetic procedures, rising adoption among
geriatric individuals, increasing public awareness about cosmetic procedures,
the availability of technologically advanced & user-friendly products, and
the increasing demand for aesthetic treatments among men.
Facial aesthetic products segment is expected to hold the largest share of
the medical aesthetics market in 2019
On the basis of products, the market is segmented into facial
aesthetic products (dermal fillers, botulinum toxin, microdermabrasion,
and chemical peels); body contouring devices (nonsurgical fat reduction
devices, cellulite reduction devices, and liposuction devices); cosmetic
implants, facial implants, and gluteal implants]; hair removal devices (laser
hair removal devices and IPL hair removal devices); skin aesthetic devices
(laser resurfacing devices, nonsurgical skin tightening devices, micro-needling
products, and light therapy devices); tattoo removal devices; thread lift
products; physician-dispensed cosmeceuticals and skin lighteners;
physician-dispensed eyelash products; and nail treatment lase devices. The
facial aesthetic products segment is expected to account for the largest share
of the market in 2019. The large share of this segment is attributed to the
growing patient demand for facial aesthetic treatments, increasing disposable
income and spending capabilities, and the rising geriatric population across
the globe.
Clinics, hospitals, and medical spas are expected to be the fastest-growing
end users in the medical aesthetics market during the forecast period
(2020“2025)
On the basis of end user, the market is segmented into clinics, hospitals,
and medical spas; beauty centers; and home care. The clinics, hospitals, and
medical spas segment is estimated to account for the largest share of the
global market in 2019. This end-user segment is also expected to be
fastest-growing end-user segment during the forecast period, owing to the
increasing number of clinics and medical spas and the high availability of
financial and infrastructural resources with hospitals, including
technologically advanced devices, trained staff, and skilled professionals to
perform aesthetic procedures.
Regional Growth Analysis:
North America to
dominate the medical aesthetics market in 2019
Geographically, the market is segmented into North America (the US and Canada), Europe (Germany, the
UK, France, Italy, Spain and the
Rest of Europe), Asia Pacific (Japan, China, India, South Korea, Australia, Indonesia, Thailand and
the Rest of Asia
Pacific), Latin
America (Brazil, Mexico, Rest of the
latin america) and the Middle
East and Africa. North America is expected to account
for the largest share of the global market in 2019. The large share of this
region in the global market can be attributed to the growing procedural volume
for aesthetic procedures and the high adoption rate of novel technologies in
this region.
Request For Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=885
Key Players:
The major players operating in the medical aesthetics market are
Allergan-AbbVie(US), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera,
Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Galderma
(Switzerland),
Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox,
Inc. (South Korea),
Sientra, Inc. (US), Sinclair Pharma plc (UK), Syneron Medical, Ltd. (US), and
Baush Health, Inc. (US).
| Company Name | Contact Person | Contact Number | Email Id | Website | Address |
|---|---|---|---|---|---|
| Marketsandmarkets | 9767961559 | newsletter@marketsandmarkets.com | https://www.marketsandmarkets.com/ |
Resonant Botanicals has introduced their latest flagship product, ROYAL. This brand-new formula draws on the comments of long time customers about...Read More
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, ...Read More
science-backed prenatal products helping couples conceive healthy pregnancies, today announced the launch of its first line of clean, science-backed m...Read More
Tabula Rasa Ventures, a venture capital firm dedicated to building an impact-focused, community-led psychedelic industry, announced the launch ...Read More
The American Society of Ketamine Physicians (ASKP) was formed in 2016 after the original founders met at the KRIYA conference and chose to form...Read More
